The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 451 participants.

Also called NCT01617434

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 451 participants (enrolled count) (from the registry)
Sponsor
  • Novo Nordisk Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01617434
  • EudraCT 2011-002696-41
Other papers using this trial's data
  • Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo-controlled trial Diabetes, obesity & metabolism, 2015-11 DOI, PubMed 26179619, PMC5054929 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Argentina, Canada, Finland, Germany, India, Mexico, Netherlands, Serbia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01617434. Randomized; double masking; primary purpose treatment. Start 2012-09 (registry gives no type); primary completion 2013-10 (actual). Results posted on 2014-10-28.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Condition
Diabetes
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
liraglutide
Intervention (Drug)
placebo
Lead sponsor
Novo Nordisk A/S (class: industry)

Record details

Record id
cardio:ct-nct01617434
Content hash
4ff75964b4e27942a1110cb048de118f0c8d76f409194808bc4b83b587234442